Randomized Trial of Monthly Versus As-Needed Intravitreal Ranibizumab for Radiation Retinopathy-Related Macular Edema: 1-Year Outcomes. [electronic resource]
Producer: 20201002Description: 165-173 p. digitalISSN:- 1879-1891
- Adult
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- administration & dosage
- Combined Modality Therapy
- Female
- Humans
- Intravitreal Injections
- Laser Coagulation
- Macular Edema -- diagnostic imaging
- Male
- Melanoma -- radiotherapy
- Middle Aged
- Prospective Studies
- Radiation Injuries -- diagnostic imaging
- Radiotherapy -- adverse effects
- Ranibizumab -- administration & dosage
- Retina -- radiation effects
- Tomography, Optical Coherence
- Treatment Outcome
- Uveal Neoplasms -- radiotherapy
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Visual Acuity -- physiology
- Young Adult
- Uveal Melanoma
No physical items for this record
Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.